GILD vs ULBI · P/E 18, rev $7.80B vs rev $95.4M
Gilead Sciences Inc (GILD) versus Ultralife Corporation (ULBI) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Ultralife Corporation (ULBI) is a electrical equipment & parts company listed on NASDAQ.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported ULBI revenue for 2026-06-30 was $95.4M. Net income was $2.1M. ULBI currently screens at market cap $104.8M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. ULBI currently screens at market cap $104.8M.
Not investment advice. Open the GILD and ULBI stock pages for the full models.
Not investment advice.